Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.000
+0.040 (2.04%)
At close: Mar 27, 2026, 4:00 PM EDT
1.951
-0.049 (-2.44%)
After-hours: Mar 27, 2026, 7:32 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $331.77 million as of March 27, 2026. Its market cap has increased by 12,973.19% in one year.
Market Cap
331.77M
Enterprise Value
198.46M
1-Year Change
12,973.19%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $331.77M, an increase of 341.96%. That is a compound annual growth rate of 35.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 331.77M | -5.25% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 344.68M |
| Immuneering | 343.95M |
| Neurogene | 343.10M |
| Opus Genetics | 337.96M |
| PepGen | 337.28M |
| Climb Bio | 333.42M |
| Forte Biosciences | 330.46M |
| Bicycle Therapeutics | 326.23M |